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Abstract
Background: Simple bone cysts are common benign lytic bone lesions in children. The main goals of treatment for
bone cysts are to prevent pathological fractures, support the healing process, and prevent recurrence. This
retrospective study compared fixation with titanium elastic intramedullary nailing (TEN) versus aspiration and
injection of autogenous bone marrow (ABM) for the treatment of simple bone cysts in children.
Methods: Forty-six patients (mean follow-up, 62 months; range, 34–71 months) who presented with bone cysts (30
in the humerus, 16 in the femur) from January 2006 to December 2012 were retrospectively evaluated. Patients
were treated with either TEN or ABM injection. Radiographs were evaluated according to previously established
criteria. Clinical evaluations of pain, infection, additional fractures, and range of motion were performed.
Results: After treatment, all patients were pain-free and had normal range of motion in adjacent joints. In the ABM
group, 14 (60.9 %) bone cysts completely healed, six (26.1 %) healed with small residuals after two injections, and
three (13.0 %) recurred. In the TEN group, 16 (69.6 %) bone cysts completely healed, four (17.4 %) healed with small
residuals, and three (13.0 %) recurred. There were no significant differences in radiographic outcomes between
groups at the final follow-up (P > 0.05). Three patients developed skin irritation as a result of the nail ends.
Additional fractures occurred in four patients who underwent ABM injection and in two patients who underwent
TEN. No significant associations were found between pathological fractures and cyst activity, location, or treatment
outcomes in the patients studied.
Conclusions: Both TEN and ABM injection are safe and effective treatment for bone cysts. ABM injection promotes
osteogenic differentiation of bone marrow stromal cells; multiple injections can reduce the likelihood of recurrence.
TEN stabilizes the affected bone and thus allows early limb mobilization. It also reduces pressure in the capsule wall
by continuous decompression to promote cyst healing. ABM injections can be used to treat cyst recurrence after
previous TEN, with favorable results.
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Background
Bone cysts are common benign lytic bone lesions in chil-
dren. These lesions mainly occur in the proximal hu-
merus and femur. They are usually diagnosed after
pathological fracture but may be an incidental finding.
Simple bone cysts are believed to be self-limiting be-
cause they disappear with skeletal maturity. The main
goals of treatment are thus prevention of pathological
fractures, support of the healing process, and prevention
of recurrence [1, 2].
Treatments for bone cysts include curettage and bone
grafting, aspiration and injection of autogenous bone
marrow (ABM) or methylprednisolone, and fixation with
titanium elastic intramedullary nail (TEN). Curettage
and bone grafting were historically the preferred treat-
ment for bone cysts. However, the results were disap-
pointing because of the high rate of recurrence [3, 4].
Aggressive surgical curettage has been associated with
complications including infection, coxa vara, physeal
damage, limb shortening, increased blood loss, patho-
logical fracture, and a prolonged period of postoperative
immobilization [1]. Scaglietti [5] reported that local in-
jection of methylprednisolone acetate had a favorable
outcome rate of 90 % in the treatment of bone cysts.
However, the recurrence rate following steroid injection
is as high as 13 %, and the treatment commonly requires
several injections [6]. Limb-length discrepancies have
also been reported in 5 to 15 % of patients treated with
steroid injection [7, 8].
Biological treatment methods such as injection of
autogenous or allogeneic ABM or bone substitutes
can reportedly optimize results [9]. Autogenous ABM
with osteoinductive potential has been used as an al-
ternative to curettage and bone grafting [6]. Aspir-
ation of bone cysts is sufficient to relieve pressure in
the cyst and evacuate the cyst fluid, which has high
bone-resorbing activity. Bone marrow has osteogenic
capacity, promoting cyst healing as well as any other
material [10]. Multiple injections can achieve ad-
equate obliteration of bone cysts in some cases [11].
However, such aspiration and percutaneous treat-
ments do not provide early mechanical stabilization
of the weakened bone [12].
TEN has been used for treatment of unicameral bone
cyst associated with long bone fracture, with favorable
results [13]. TEN can provide prompt stabilization of the
affected bone to prevent pathological fracture and allow
for early mobilization [14]. Pogorelić [15] reported that
18 bone cysts treated with TEN healed completely with
no recurrence. In a study by Masquijo [16], unicameral
bone cysts were treated by continuous decompression
with TEN; a successful outcome was observed in 89.5 %
of cases (26 total healing, 17 healing with residual radio-
lucent areas), and four cysts recurred.
Both ABM and fixation with TEN have been conven-
tional treatment methods for bone cysts in our depart-
ment. In the present study, we retrospectively reviewed
cases of bone cyst treated with ABM or TEN. The pur-
pose of the study was (1) to compare the clinical out-
comes and healing of bone cysts after ABM versus TEN
and (2) to evaluate the characteristics of ABM and TEN
in the treatment of simple bone cysts in children.
Methods
We performed a retrospective review of 46 patients with
simple bone cysts treated from January 2006 to Decem-
ber 2012. Bone cysts were diagnosed based on their
characteristic radiographic appearance and histological
findings. After radiographic diagnosis, bone cysts were
observed without treatment for 3 to 6 months. If bone
cysts showed improvement during this time, observation
continued with follow-up at 3-month intervals. If bone
cysts showed progression or if pathological fracture oc-
curred, ABM or TEN was performed. The surgeon chose
the treatment method based on factors such as the loca-
tion of the bone cyst and the presence of fracture. Thirty
cysts occurred in the humerus and 16 in the femur. Pa-
tients with pathological fracture underwent
immobilization with a brace for 3 weeks before surgical
intervention. Informed consent to undergo treatment
with ABM injection or TEN was obtained from all pa-
tients and their parents or guardians. Patients who had
previously received any treatment other than
immobilization for pathological fractures were excluded
from the study, as were patients lost during follow-up.
The choice of treatment was based on several factors, in-
cluding advantages of the respective methods, patient
preference, characteristics of the bone cysts, the neces-
sity of eventual surgery to remove the nails with TEN,
and the possible need for multiple surgeries with ABM.
Patients or guardians helped to decide on the appropri-
ate treatment before surgery. Informed consent to
undergo treatment with ABM injection or TEN was ob-
tained from all patients and their parents or guardians.
TEN provides mechanical stability of pathological frac-
tures; therefore bone cysts in the calcar femorale and
those with fractures reducing the strength of cortical
bone were generally treated with TEN. The flow of bone
marrow can be blocked in multiseptated bone cysts,
which can result in cyst recurrence with ABM treatment.
TEN can break the septation in bone cysts, allowing the
free flow of cyst fluid and reducing cyst pressure.
ABM aspiration and injection technique
Surgery was performed under general anesthesia. Fluor-
oscopy was used intraoperatively to determine the pos-
ition of bone cysts. Percutaneous bone marrow puncture
was performed, and clear or straw-colored fluid was
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aspirated. For multilocular bone cysts, each cavity was
aspirated separately. After removal of all cyst fluid, bone
marrow was aspirated from the iliac crest and injected
into the cyst. The volume of bone marrow aspirated
from a single site was 2 to 3 ml. Most patients received
10 to 15 ml, collected from several sites on the iliac
crest. If a cyst was not completely healed after 8 months,
another injection was performed.
TEN technique
TEN was performed for internal fixation. The diameter
of the intramedullary nail (Synthes, Solothurn,
Switzerland) ranged from 2 to 4 mm, with 0.5-mm in-
crements between available diameters. The size and
length were chosen based on the size of the bone on op-
erative radiographs. Incisions approximately 1 cm in
length were made medially and laterally in the distal
limb. The medullary canal was opened an adequate dis-
tance from the growth plate. The nail was gradually in-
troduced into the medullary canal and through the bone
cyst under fluoroscopic guidance. Nail stability was veri-
fied by rotating the limb under fluoroscopy. The nail
end was trimmed to avoid skin irritation. If necessary, a
second nail was placed using the same method. Patients
gradually returned to their normal activities 24 h after
surgery. Full activity, including weight bearing, was re-
sumed 4 weeks postoperatively.
Clinical and radiographic assessments were performed
6 and 12 weeks after surgery and again after 6 to
24 months. Clinical evaluations for pain, infection, add-
itional fractures, and range of motion were also per-
formed. The radiographic criteria described by Capanna
et al. [17] were used to classify the healing of bone cysts:
Grade I, completely healed; Grade II, healed with small
residuals; Grade III, recurrence of an initially healed cyst
with increasing signs of radiolucency and cortical thin-
ning; and Grade IV, no response after surgery. Grades I
and II represent successful treatment, while Grades III
and IV represent treatment failure. The radiographic
outcomes were evaluated by radiologists and orthopedic
surgeons. If disagreement occurred regarding a radio-
graph, an extra evaluation was performed by double-
blinded radiologists and orthopedic surgeons.
Pearson’s chi-squared test was used to compare gen-
eral data and the condition of bone cyst healing between
the two treatment groups. Fisher’s exact test was used
for theoretical samples of less than five. P values <0.05
were considered statistically significant. Kappa values
were used to determine intraobserver and interobserver
repeatability and reliability.
Results
Sixteen bone cysts were located in the humerus and
seven in the femur in the ABM group, whereas 14 were
located in the humerus and nine in the femur in the
TEN group (P > 0.05). The mean age at diagnosis was
7.9 ± 3.3 years in the ABM group and 8.3 ± 3.1 years in
the TEN group (P > 0.05). The mean age at surgery was
8.8 ± 2.9 years and 9.1 ± 3.2 years, respectively (P > 0.05).
There were 14 male and nine female patients in the
ABM group and 15 male and eight female patients in
the TEN group (P > 0.05). The mean follow-up period
was 62 months (range, 34–71 months). There was no
significant difference in cyst location, sex, age at diag-
nosis, or age at first surgery between the two groups
(P > 0.05). Eight patients had active cysts and 15 had
latent cysts in the ABM group, while 11 patients had
active cysts and 12 had latent cysts in the TEN group
(P > 0.05). There was no significant difference in cyst
activity, location, or presence of fracture between the
two groups (P > 0.05). The interobserver reliability
ranged from 73.3 to 86.7 % (Kappa coefficient, 0.761–
0.847). Intraobserver repeatability ranged from 83.3 to
93.3 % (Kappa coefficient, 0.821–0.925) (P < 0.01).
In the ABM group, 14 (60.9 %) patients had patho-
logical fractures, five (21.8 %) had pain or loss of func-
tion with no radiographic evidence of fracture, and four
(17.3 %) had cysts diagnosed as an incidental radio-
graphic finding. In the TEN group, 15 (65.2 %) patients
had pathological fractures, five (21.8 %) had pain or loss
of function without fracture, and three (13.0 %) had
cysts diagnosed as an incidental finding. There was no
significant difference in the reason for detection of bone
cysts between the two groups (P > 0.05). None of the
fractures involved a growth plate (Table 1).
According to the criteria described by Capanna et al.
[17], 14 (60.9 %) bone cysts in the ABM group achieved
Grade I (complete healing) and six (26.1 %) achieved
Grade II (healing with small residuals) at 18 months
after two injections (Fig. 1). Three (13.0 %) cysts im-
proved initially and subsequently recurred. In these
cases, two ABM injections were performed and the bone
cysts were healed with residuals after 6 months. In the
TEN group, 16 (69.6 %) bone cysts achieved Grade I and
four (17.4 %) cysts achieved Grade II after 18 months.
The intramedullary nails were removed after 18 months
(Fig. 2). Radiographically, two (8.7 %) limbs showed
slight deformities in the sagittal and frontal planes.
Three (13.0 %) cysts gradually improved and then re-
curred after 12 months. In cases of recurrence, ABM in-
jection was performed and the bone cysts were healed
with small residuals after 8 months. No patient in either
group had Grade IV cysts. There was no significant dif-
ference in the outcomes between the two groups at the
final follow-up, according to the criteria of Capanna et
al. [17] (P > 0.05) (Table 2, Fig. 3).
On clinical evaluation, all patients were pain-free and
had normal range of motion in the joints after surgery.
Li et al. BMC Musculoskeletal Disorders  (2016) 17:343 Page 3 of 8
Skin irritation resulting from nail ends developed in
three (13.0 %) patients in the TEN group; irritation grad-
ually resolved after nail removal. Pathological fractures
developed in four (17.3 %) patients in the ABM group
and in one (4.3 %) in the TEN group. In these cases a
plaster cast was applied for 4 weeks, and the bone cysts
healed to Grade II. Three (13.0 %) patients in the ABM
group and one (4.3 %) in the TEN group developed skin
infections. These infections healed well with antibiotic
treatment.
Our subsequent analysis explored the relationships be-
tween the various factors associated with pathological
fractures in all patients (Table 3). Eleven of 16 femoral
cysts and 18 of 30 humeral cysts were associated with
pathological fracture (P < 0.05). Among all 29 patients
with fracture, 21 cysts healed to Grade I, six to Grade II,
and two to Grade III. Among the 17 patients without
fracture, nine cysts healed to Grade I, four to Grade II,
and four to Grade III. There was no significant associ-
ation between pathological fracture and the form of the
bone cyst (unilocular versus multilocular) (P > 0.05).
There were no significant associations between patho-
logical fracture and cyst activity or outcome according
to the criteria of Capanna et al. [17] (P > 0.05).
Discussion
Simple bone cysts are common bone lesions in children
first described by Virchow two centuries ago. The eti-
ology of bone cysts is uncertain; possible etiologies in-
clude localized failure of ossification, entrapped
intramedullary synovial tissue, or restricted blood supply
resulting from venous blockage. Simple bone cysts are
prone to pathological fracture resulting from minor in-
jury, particularly enormous bone cysts of the calcar
femorale. Bone cysts are usually discovered because of
pathological fracture but can be incidental findings. Ac-
tive bone cysts in the humerus or femur are gradually
progressive. Though simple bone cysts are often asymp-
tomatic and tend to disappear with skeletal maturity, re-
peated pathological fractures and growth arrest can
occur before spontaneous resolution. Therefore, the goal
of treatment is to prevent pathological fractures and the
resulting skeletal deformities during growth [18]. The
Table 1 Demographic data and general data for fixation of











Femur 7 (30.4 %) 9 (39.1 %) 0.75
Humeral 16 (69.6 %) 14 (60.9 %)
Age at diagnosisa 7.9 ± 3.3 8.3 ± 3.1 0.67
Age at first
surgerya
8.8 ± 2.9 9.1 ± 3.2 0.74
Female 9 (39.1 %) 8 (37.8 %) 1.00





2.1 ± 2.2 1.9 ± 2.1 0.75
Active 8 (34.8 %) 11 (47.8 %) 0.55
Latent 15 (65.2 %) 12 (52.2 %)
Unilocular 10 (43.5 %) 9 (39.1 %) 1.00
Multilocular 13 (56.5 %) 14 (60.9 %)
Fractures 14 (60.9 %) 15 (65.2 %) 0.84
Pain or inability
without fracture
5 (21.8 %) 5 (21.8 %)
Incidental
findings
4 (17.3 %) 3 (13.0 %)
aThe values in the groups columns are given as the mean and
standard deviation
Fig. 1 Radiographs of a 7-year-old boy evaluated for arm pain and loss of function. a A bone cyst is present in the proximal humerus with deviation of
the axis. b A significantly displaced pathological fracture occurred after a sudden fall. c The lesion shows signs of healing after aspiration and injection of
bone marrow. d The bone cyst is healed 18 months postoperatively. e The radiograph shows the bone cyst healed at 68-month follow-up
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treatment methods for bone cysts include curettage and
grafting, aspiration and injection, damage to the cyst
wall and lining, cyst decompression, mechanical support,
or a combination of these strategies. At our institution, a
percutaneous technique is used instead of open opera-
tions such as curettage and grafting. The percutaneous
technique is safe and effective; ABM, methylpredniso-
lone acetate, cortisone, demineralized bone matrix,
calcium-phosphate bone cement, and intramedullary
nails can be applied to bone cysts with various results [1,
6, 18, 19]. In this study, we retrospectively reviewed pa-
tients treated with ABM injection or TEN to evaluate
clinical outcomes and radiographic findings. There was
no significant differences in outcomes between the ABM
and TEN groups at the final follow-up, according to the
criteria of Capanna et al. [17] (P > 0.05). However, TEN
and ABM injection have different characteristics during
the treatment process.
Lokiec et al. [20] first introduced ABM grafting for
bone cyst treatment with successful results. Bone mar-
row injection provides osteoprogenitor cells, stimulates
new bone formation, and promotes healing of bone cysts
because of its osteoinductive properties. Clinical studies
have suggested that aspirated bone marrow promotes
bone cyst resolution [20]. Osteoblast progenitor cells
and bone marrow stem cells have the potential to differ-
entiate into osteoblasts. The optimum volume of bone
marrow to inject is defined by the osteoblast progenitor
cells. The number of cells increases as the aspiration vol-
ume increases [21]. However, the number of cells at the
site of the iliac bone is limited. When the volume of as-
pirated bone marrow increases to more than 2 to 3 ml,
the concentration of osteoblast progenitor cells is re-
duced as peripheral blood is mixed with the bone mar-
row. To maximize the number of available cells, we
recommend that total volume per site in the iliac bone
should be limited to 2 to 3 ml, similar to the recommen-
dation made in another study [9].
A second ABM injection was performed in this study
in patients with incomplete healing at 8 months postop-
eratively. Two injections can promote osteogenic differ-
entiation and reduce the cyst recurrence rate. Fourteen
(60.9 %) bone cysts completely healed to Grade I, and
six (26.1 %) healed to Grade II. In a study of ABM treat-
ment in patients with bone cysts, Docquier et al. [22] re-
ported that 13 (76 %) cases exhibited slow regression
Fig. 2 Radiographs of an 8-year-old girl who presented with pathological fracture of the right humerus. a Anteroposterior radiograph at presentation.
A bone cyst with pathological fracture is located in the proximal metaphysis and diaphysis of the humerus. b Fixation with flexible intramedullary nails
was performed. c Three months after surgery the lesion is significantly smaller and shows sings of healing. d At 28 months the bone cyst has resolved,
and the intramedullary nails are removed. e At 61-month follow-up the bone cyst is completely healed without refracture or deviation of the axis
Table 2 The treatment outcomes of flexible intramedullary
nailing and injection of bone marrow








0 3 (13.0 %) -
Additional
fracture
4 (17.3 %) 1 (4.3 %) -
Skin
infection
3 (13.0 %) 1 (4.3 %) -
The first outcome by criteria of Capanna et ala
Grade I 14 (60.9 %) 16 (69.6 %) 0.77
Grade II 6 (26.1 %) 4 (17.4 %)
Grade III 3 (13.0 %) 3 (13.0 %)










a The first outcome was the result by two injections of bone marrow or
fixation of intramedullary nailing after 18 month postoperatively. b The three
patients in Grade III were preformed with injection of bone marrow as a result
of healing of bone cysts with small residuals
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and progressive healing, two exhibited no response, and
two developed recurrence. Bone cysts in three (13.6 %)
patients gradually diminished to about one-third of their
original size at 12 months with two injections. Another
two injections were performed for partially healed cysts
with residuals. Zamzam et al. [9] reported that repeated
injections of ABM are necessary to reduce of the recur-
rence of bone cysts. Other authors have also recom-
mended multiple injections of ABM in the treatment of
bone cysts [2]. Connolly et al. [23] reported that there is
no harm in multiple injections and that they may be
beneficial in many cases.
According to previous studies, TEN has rapidly been
gaining popularity as a treatment for simple bone cysts
in long bones. Pogorelić et al. [15] reported that 18 bone
cysts treated with TEN were healed completely at
3 months with no cyst recurrence. De Sanctis et al. [24]
reported that 31 (65.9 %) of 47 cysts treated with TEN
completely healed and that 16 (34.1 %) healed with re-
sidual radiolucency. Glanzmann et al. [25] performed
TEN to treat 20 patients; 16 cysts healed completely and
four healed with residual areas without recurrence.
Kanellopoulos et al. [1] reported that seven of nine cysts
consolidated completely (Neer stage I) and that two of
nine cysts consolidated partially (Neer stage II).
The choice of treatment between ABM and TEN in
this study was based on several factors, including ad-
vantages of the respective methods, patient prefer-
ences, characteristics of the bone cyst, the necessity
of surgery for nail removal in TEN, and the need for
multiple procedures in ABM. Patients or guardians
chose treatment methods before surgery. There were
no significant differences in cyst location, sex, age at
diagnosis, or age at first surgery between the two
treatment groups (P > 0.05). Likewise, there were no
significant differences in cyst activity, location, or
presence of fractures between the two groups (P >
0.05). We plan to perform a prospective study on the
treatment of bone cysts in the future.
The presence of bone cysts affect bone strength, and
pathological fractures are a common reason for
hospitalization. Bone cysts in the proximal femur are
generally located in the calcar femorale, which plays a
significant role in the strength of the intertrochanteric
region of the femur and stability of intertrochanteric
fractures. Lokiec et al. [20] reported that percutaneous
injection of ABM could weaken the consolidation of
bone cysts. Additionally, aspiration of cyst fluid with
percutaneous injection does not initially enhance the
mechanical stability of cysts. Intramedullary nails pro-
vide mechanical stabilization of pathological fractures in
the femur and humerus. Nail fixation is invasive surgery,
but does not destroy the structure of the bone cyst. TEN
has two main benefits: continuous cyst decompression
and early immediate stabilization of the involved bone,
Fig. 3 Radiographs of a 5-year-old boy who presented with leg pain and loss of function. a A bone cyst is present in the proximal metaphysis of
the femur without pathological fracture. b Flexible intramedullary nailing was used to fix and decompress the bone cyst. c The lesion shows signs
of healing 6 months after surgery. d At 26 months the bone cyst is healed and the nail is removed. e The lesion is completely healed at
59-month follow-up
Table 3 The relative factors associated with pathological
fracture
Parameter Fracture No fracture P value
Number 29 17 -
Femur 11 (37.9 %) 5 (29.4 %) 0.79
Humeral 18 (62.1 %) 12 (70.6 %)
Cyst activitya 2.0 ± 2.2 2.5 ± 2.7 0.49
Unilocular 12 (41.4 %) 7 (41.2 %) 1.00
Multilocular 17 (58.6 %) 10 (51.5 %)
The first outcome by criteria of Capanna et alb
Grade I 21 9 0.23
Grade II 6 4
Grade III 2 4
aThe values in the groups columns are given as the mean and
standard deviation
bThe first outcome was the result by two injections of bone marrow or fixation
of intramedullary nailing after 18 month postoperatively
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which permits early mobilization and a return to the
normal activities of pre-teen patients [1]. Journeau et al.
[12] reported that TEN should be preferred for weight-
bearing segments, regardless of whether the bone cyst is
associated with fracture. The authors recommended that
patients undergoing ABM injection should not be
allowed to perform strenuous exercise for 1 month after
the procedure. Bone cysts in the proximal femur, espe-
cially those in the calcar femorale, should be treated
with fixation by TEN.
Decompression of bone cysts is performed to treat
venous obstruction that leads to intramedullary accumu-
lation and later cavity formation [26]. Percutaneous dril-
ling of multiple sites with Kirschner wires and prolonged
decompression of bone cysts with cannulated screws or
intramedullary nails left in place have been advocated
for the treatment of bone cysts. Drilling leads to decom-
pression and decreases the pressure within the bone cyst
[27, 28]. TEN decompresses bone cysts and breaks down
the capsule wall to allow the capsule fluid to flow into
the medullary cavity. Decompression of bone cysts re-
duces the pressure on the cortex and promotes regener-
ation of newly formed bone [3]. We repeatedly rotated
the nail in the bone cyst to break down the structure of
the capsule wall, which reduces the production of cap-
sule fluid by the cyst and decompresses the bone cyst.
Some authors have recommended performing multiple
perforations of the cyst wall, breaking the intralesional
septa, and/or curetting the cyst membrane [19, 25].
Glanzmann et al. [25] reported that it was unclear
whether insertion of nails and consecutive decompres-
sion of bone cysts can lead to migration of pathological
tissue, provoking recurrence. However, that study com-
pared intramedullary nailing with steroid injection for
bone cysts and found no difference in healing times and
fewer complications in patients who underwent nailing
[12]. In a study by Masquijo [16], unicameral bone cysts
were treated with continuous decompression with intra-
medullary nailing. In that study, successful results were
observed in 89.5 % of cases (26 total healing, 17 healing
with residual radiolucent areas); four cysts recurred.
In the TEN group in the present study, bone cysts in
16 (69.6 %) patients were completely healed within
12 months. Four (17.4 %) bone cysts had healed with re-
siduals at the last follow-up. Glanzmann et al. [25] re-
ported that 16 of 22 cysts treated with TEN healed
completely and four healed to Grade II, with a minimal
complication rate. TEN should be preferred for treat-
ment of bone cysts, based on a success rate of 94 % in
32 unicameral bone cysts. The bone cysts in three pa-
tients gradually diminished initially and recurred after
6 months. After injection of bone marrow, these bone
cysts healed with small residuals after 12 months. The
combined biological and mechanical treatment of simple
bone cysts has also been described in recent studies. In-
jection of ABM and demineralized bone matrix in
addition to TEN has also been used for stabilization of
bone cysts [1]. Rappet al. [29] reported that the combin-
ation of TEN, artificial bone substitute, and autologous
platelet-rich plasma enhanced the treatment of bone
cysts in children, with no resulting complications.
Conclusion
Both fixation by TEN and ABM injection are safe and
effective methods for treatment of bone cysts. After
treatment with ABM or TEN, the expected natural his-
tory is that the cyst gradually shrinks and disappears
after skeletal maturation. Fixation with TEN and limiting
activity may improve the healing of bone cysts and pre-
vent pathological fracture in children. ABM injection in-
duces osteogenic differentiation of bone marrow stromal
cells; multiple injections can reduce the likelihood of
cyst recurrence. TEN provides stabilization of the af-
fected bone and thus allows early limb mobilization.
TEN also allows continuous decompression, which re-
duces the pressure on the capsule wall and promotes
bone cyst healing. ABM injection can be used to treat
recurrent cysts after previous TEN, with favorable
results.
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